The Patent Finder

Dermex Pharmaceuticals, LLC

Also on record
Records under this name other than patents Dermex Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Dermex Pharmaceuticals, LLC

PatentTitleStatus Expires Confidence
US 6,774,124Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions
Term ended
Term ended May 3, 2018 · From the USPTO record
Term endedTerm ended May 3, 2018From the USPTO record
US 6,476,014Chelated 8-hydroxyquinoline for the treatment of epithelial lesions
Term ended
Term ended Feb 10, 2018 · From the USPTO record
Term endedTerm ended Feb 10, 2018From the USPTO record
US 7,060,696Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions
Term ended
Term ended Feb 10, 2018 · From the USPTO record
Term endedTerm ended Feb 10, 2018From the USPTO record
US 7,846,919Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions
Term ended
Ended no later than Feb 10, 2018 · From the USPTO record
Term endedEnded no later than Feb 10, 2018From the USPTO record
US 8,012,954Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions
Term ended
Ended no later than Feb 10, 2018 · From the USPTO record
Term endedEnded no later than Feb 10, 2018From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited